Facebook
Twitter
LinkedIn
Forward
Mary Peavey, MD, MSc, will provide an overview of the fertility preservation options available to male and female patients receiving treatment at UNC hospitals.
|
Exploration of diet related factors that may affect patient response to anti-cancer immunotherapy.
|
Ronny Bell, PhD, MS, and Marc Emerson, PhD, MPH, in this collaborative session will provide context regarding the cancer disparities and efforts to address these disparities
|
This will be an interactive, introductory session on computed tomography with an emphasis on anatomy and common oncology findings.
|
Rodney Haring, PhD, MSW, will discuss how treaty and wampum conversations have impacted the cancer care of Indigenous populations. Building on this foundation, Dr.
|
Dr.
|
Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Kate Foreman, MS, CGC helps us navigate this field.
|
Join Transfusion Medicine and Blood Bank Fellow, Mariama Evans, MD, for a review of transfusion reactions and their laboratory workup. Specific topics to include the most common transfusion reactions seen in cancer patients and the laboratory techniques utilized, such as Direct Antiglobulin Test (DAT) and elutions.
|
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.
|
In this webinar, Angela Smith, MD, MS, FACS discusses the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
|